These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24780501)

  • 1. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial.
    Tardif JC; Ballantyne CM; Barter P; Dasseux JL; Fayad ZA; Guertin MC; Kastelein JJ; Keyserling C; Klepp H; Koenig W; L'Allier PL; Lespérance J; Lüscher TF; Paolini JF; Tawakol A; Waters DD;
    Eur Heart J; 2014 Dec; 35(46):3277-86. PubMed ID: 24780501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial.
    Nicholls SJ; Andrews J; Kastelein JJP; Merkely B; Nissen SE; Ray KK; Schwartz GG; Worthley SG; Keyserling C; Dasseux JL; Griffith L; Kim SW; Janssan A; Di Giovanni G; Pisaniello AD; Scherer DJ; Psaltis PJ; Butters J
    JAMA Cardiol; 2018 Sep; 3(9):815-822. PubMed ID: 30046828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.
    Tardif JC; Grégoire J; L'Allier PL; Ibrahim R; Lespérance J; Heinonen TM; Kouz S; Berry C; Basser R; Lavoie MA; Guertin MC; Rodés-Cabau J;
    JAMA; 2007 Apr; 297(15):1675-82. PubMed ID: 17387133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial.
    Nicholls SJ; Puri R; Ballantyne CM; Jukema JW; Kastelein JJP; Koenig W; Wright RS; Kallend D; Wijngaard P; Borgman M; Wolski K; Nissen SE
    JAMA Cardiol; 2018 Sep; 3(9):806-814. PubMed ID: 30046837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.
    Nissen SE; Tsunoda T; Tuzcu EM; Schoenhagen P; Cooper CJ; Yasin M; Eaton GM; Lauer MA; Sheldon WS; Grines CL; Halpern S; Crowe T; Blankenship JC; Kerensky R
    JAMA; 2003 Nov; 290(17):2292-300. PubMed ID: 14600188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
    Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM;
    JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.
    Nicholls SJ; Puri R; Anderson T; Ballantyne CM; Cho L; Kastelein JJ; Koenig W; Somaratne R; Kassahun H; Yang J; Wasserman SM; Scott R; Ungi I; Podolec J; Ophuis AO; Cornel JH; Borgman M; Brennan DM; Nissen SE
    JAMA; 2016 Dec; 316(22):2373-2384. PubMed ID: 27846344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression.
    Berry C; L'Allier PL; Grégoire J; Lespérance J; Levesque S; Ibrahim R; Tardif JC
    Circulation; 2007 Apr; 115(14):1851-7. PubMed ID: 17389269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano.
    Nicholls SJ; Tuzcu EM; Sipahi I; Schoenhagen P; Crowe T; Kapadia S; Nissen SE
    J Am Coll Cardiol; 2006 Mar; 47(5):992-7. PubMed ID: 16516083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study.
    Andrews J; Janssan A; Nguyen T; Pisaniello AD; Scherer DJ; Kastelein JJ; Merkely B; Nissen SE; Ray K; Schwartz GG; Worthley SG; Keyserling C; Dasseux JL; Butters J; Girardi J; Miller R; Nicholls SJ
    Cardiovasc Diagn Ther; 2017 Feb; 7(1):45-51. PubMed ID: 28164012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden.
    Kataoka Y; Andrews J; Duong M; Nguyen T; Schwarz N; Fendler J; Puri R; Butters J; Keyserling C; Paolini JF; Dasseux JL; Nicholls SJ
    Cardiovasc Diagn Ther; 2017 Jun; 7(3):252-263. PubMed ID: 28567351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Libby P; Thompson PD; Ghali M; Garza D; Berman L; Shi H; Buebendorf E; Topol EJ;
    JAMA; 2004 Nov; 292(18):2217-25. PubMed ID: 15536108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
    Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome　- The ODYSSEY J-IVUS Trial.
    Ako J; Hibi K; Tsujita K; Hiro T; Morino Y; Kozuma K; Shinke T; Otake H; Uno K; Louie MJ; Takagi Y; Miyauchi K
    Circ J; 2019 Sep; 83(10):2025-2033. PubMed ID: 31434809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trying to harness the potential of HDL: wishful thinking or sound strategy?
    Fogelman AM
    Eur Heart J; 2014 Dec; 35(46):3248-9. PubMed ID: 24818600
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome.
    Rodés-Cabau J; Tardif JC; Cossette M; Bertrand OF; Ibrahim R; Larose E; Grégoire J; L'allier PL; Guertin MC
    Am J Cardiol; 2009 Sep; 104(6):750-7. PubMed ID: 19733706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.
    Nissen SE; Nicholls SJ; Wolski K; Rodés-Cabau J; Cannon CP; Deanfield JE; Després JP; Kastelein JJ; Steinhubl SR; Kapadia S; Yasin M; Ruzyllo W; Gaudin C; Job B; Hu B; Bhatt DL; Lincoff AM; Tuzcu EM;
    JAMA; 2008 Apr; 299(13):1547-60. PubMed ID: 18387931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
    Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Murakami M; Hirose E; Sato S; Ohkawa K; Ishizawa M; Yamaji H; Kawamura H; Kusachi S; Murakami T; Hina K; Ohe T
    J Am Coll Cardiol; 2010 Mar; 55(10):976-82. PubMed ID: 20202514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the PPARγ agonist pioglitazone on coronary atherosclerotic plaque composition and plaque progression in non-diabetic patients: a double-center, randomized controlled VH-IVUS pilot-trial.
    Christoph M; Herold J; Berg-Holldack A; Rauwolf T; Ziemssen T; Schmeisser A; Weinert S; Ebner B; Said S; Strasser RH; Braun-Dullaeus RC
    Heart Vessels; 2015 May; 30(3):286-95. PubMed ID: 24519403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.